ABSTRACT
We present the neonatal complications of two premature newborn infants whose placentas demonstrated placental thrombosis in the fetal circulation. Both mothers presented with a 3-day history of decreased fetal movements before delivery. The first infant presented with thrombocytopenia and disseminated intravascular coagulation. The second infant had extended bilateral extended hemorrhagic venous infarctions. Severe fetal placental vascular lesions seem to be a predisposing factor for some adverse neonatal outcomes. We present these two cases with a brief review of the literature.
KEYWORDS
Newborn - placenta - fetal thrombotic vasculopathy - brain infarct
REFERENCES
-
1
Gruenwald P.
Fetal deprivation and placental pathology: concepts and relationships.
Perspect Pediatr Pathol.
1975;
2
101-149
-
2
Ariel I, Anteby E, Hamani Y, Redline R W.
Placental pathology in fetal thrombophilia.
Hum Pathol.
2004;
35
729-733
-
3
Redline R W.
Severe fetal placental vascular lesions in term infants with neurologic impairment.
Am J Obstet Gynecol.
2005;
192
452-457
-
4
Kraus F T, Acheen V I.
Fetal thrombotic vasculopathy in the placenta: cerebral thrombi and infarcts, coagulopathies, and cerebral palsy.
Hum Pathol.
1999;
30
759-769
-
5
McDonald D G, Kelehan P, McMenamin J B et al..
Placental fetal thrombotic vasculopathy is associated with neonatal encephalopathy.
Hum Pathol.
2004;
35
875-880
-
6
Redline R W.
Placental pathology: a systematic approach with clinical correlations.
Placenta.
2008;
29(suppl A)
S86-S91
-
7
Redline R W.
Clinical and pathological umbilical cord abnormalities in fetal thrombotic vasculopathy.
Hum Pathol.
2004;
35
1494-1498
-
8
Dikmen M, Ozbabalik D, Gunes H V et al..
Acute stroke in relation to homocysteine and methylenetetrahydrofolate reductase gene polymorphisms.
Acta Neurol Scand.
2006;
113
307-314
-
9
Trabetti E.
Homocysteine, MTHFR gene polymorphisms, and cardio-cerebrovascular risk.
J Appl Genet.
2008;
49
267-282
-
10
Redline R W, Pappin A.
Fetal thrombotic vasculopathy: the clinical significance of extensive avascular villi.
Hum Pathol.
1995;
26
80-85
-
11
Redline R W.
Elevated circulating fetal nucleated red blood cells and placental pathology in term infants who develop cerebral palsy.
Hum Pathol.
2008;
39
1378-1384
-
12
Dahms B B, Boyd T, Redline R W.
Severe perinatal liver disease associated with fetal thrombotic vasculopathy.
Pediatr Dev Pathol.
2002;
5
80-85
-
13
Redline R W, Shah D, Sakar H, Schluchter M, Salvator A.
Placental lesions associated with abnormal growth in twins.
Pediatr Dev Pathol.
2001;
4
473-481
-
14
Leistra-Leistra M J, Timmer A, van Spronsen F J, Geven W B, van der Meer J, Erwich J J.
Fetal thrombotic vasculopathy in the placenta: a thrombophilic connection between pregnancy complications and neonatal thrombosis?.
Placenta.
2004;
25(suppl A)
S102-S105
-
15
Khong T Y, Hague W M.
Biparental contribution to fetal thrombophilia in discordant twin intrauterine growth restriction.
Am J Obstet Gynecol.
2001;
185
244-245
-
16
Vern T Z, Alles A J, Kowal-Vern A, Longtine J, Roberts D J.
Frequency of factor V(Leiden) and prothrombin G20210A in placentas and their relationship with placental lesions.
Hum Pathol.
2000;
31
1036-1043
Pia WintermarkM.D.
Clinical Fellow, Harvard Neonatal-Perinatal Fellowship Training Program, Division of Newborn Medicine, and Associate Research Scientist, Department of Radiology, Children's Hospital Boston
300 Longwood Avenue, Enders 961, Boston, MA 02115
eMail: Pia.Wintermark@bluemail.ch
